USPTO serial 87646517
CELLULAR MATRIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 13, 2021
- Examiner
- CHADAB, SETH WILLIG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CELLULAR MATRIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Jersey City, NJ, US
New York, NY, US
Brooklyn, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay Kaplan
Lindsay Kaplan L. Kaplan LawPO Box 4062Kingston, NY 12402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; products and preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use | ACTIVE | May 1, 2021 |
| 010 | Medical devices, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid and chitosan, sold as a unit, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments, namely, tubes, containers, syringes, needles, for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology, mesotherapy, cardiovascular, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; centrifuges for medical purposes; suture material; cases fitted for medical instruments; receptacles for applying medicines, namely, medical containers, cannula, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; containers specially adapted for storing tissue and biological samples for medical purposes; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; medical apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels | ACTIVE | May 1, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by RegenLab USA LLC
- Other trademarks owned by RegenLab USA LLC
- Other trademarks owned by RegenLab USA LLC
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named CELLULAR MATRIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 13, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 5, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Sep 5, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 5, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 5, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 10, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 10, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jan 10, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 10, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 13, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 5, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 4, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 17, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 14, 2021 | IUAF | USE AMENDMENT FILED | — |
| May 14, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 13, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 12, 2020 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 9, 2020 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 9, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 19, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 18, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 16, 2020 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jun 16, 2020 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Jun 16, 2020 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jun 16, 2020 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Jun 15, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 15, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 15, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 11, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 10, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 10, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 3, 2019 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Dec 2, 2019 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Dec 2, 2019 | PETG | PETITION TO REVIVE-GRANTED | — |
| Dec 2, 2019 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Nov 15, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 9, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 7, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 7, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 7, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 21, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 16, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 14, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 14, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 14, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 1, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 1, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 15, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 20, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 20, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 1, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 1, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 1, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 1, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 25, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 19, 2017 | NWAP | NEW APPLICATION ENTERED | — |